Cargando…
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, human papillomavirus (HPV) is currently the most common pathogen responsible for female cancers. Moreover, HPV infection is associated with many other diseases, including cutaneous and anogenital warts, and genital...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855977/ https://www.ncbi.nlm.nih.gov/pubmed/33553082 http://dx.doi.org/10.3389/fpubh.2020.552028 |
_version_ | 1783646212780457984 |
---|---|
author | Kombe Kombe, Arnaud John Li, Bofeng Zahid, Ayesha Mengist, Hylemariam Mihiretie Bounda, Guy-Armel Zhou, Ying Jin, Tengchuan |
author_facet | Kombe Kombe, Arnaud John Li, Bofeng Zahid, Ayesha Mengist, Hylemariam Mihiretie Bounda, Guy-Armel Zhou, Ying Jin, Tengchuan |
author_sort | Kombe Kombe, Arnaud John |
collection | PubMed |
description | Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, human papillomavirus (HPV) is currently the most common pathogen responsible for female cancers. Moreover, HPV infection is associated with many other diseases, including cutaneous and anogenital warts, and genital and upper aerodigestive tract cancers. The incidence and prevalence of these pathologies vary considerably depending on factors including HPV genotype, regional conditions, the study population, and the anatomical site sampled. Recently, features of the cervicovaginal microbiota are found to be associated with the incidence of HPV-related diseases, presenting a novel approach to identify high-risk women through both blood and cervical samples. Overall, the HPV repartition data show that HPV infection and related diseases are more prevalent in developing countries. Moreover, the available (2-, 4-, and 9-valent) vaccines based on virus-like particles, despite their proven effectiveness and safety, present some limitations in terms of system development cost, transport cold chain, and oncogenic HPV variants. In addition, vaccination programs face some challenges, leading to a considerable burden of HPV infection and related diseases. Therefore, even though the new (9-valent) vaccine seems promising, next-generation vaccines as well as awareness programs associated with HPV vaccination and budget reinforcements for immunization are needed. |
format | Online Article Text |
id | pubmed-7855977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78559772021-02-04 Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation Kombe Kombe, Arnaud John Li, Bofeng Zahid, Ayesha Mengist, Hylemariam Mihiretie Bounda, Guy-Armel Zhou, Ying Jin, Tengchuan Front Public Health Public Health Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, human papillomavirus (HPV) is currently the most common pathogen responsible for female cancers. Moreover, HPV infection is associated with many other diseases, including cutaneous and anogenital warts, and genital and upper aerodigestive tract cancers. The incidence and prevalence of these pathologies vary considerably depending on factors including HPV genotype, regional conditions, the study population, and the anatomical site sampled. Recently, features of the cervicovaginal microbiota are found to be associated with the incidence of HPV-related diseases, presenting a novel approach to identify high-risk women through both blood and cervical samples. Overall, the HPV repartition data show that HPV infection and related diseases are more prevalent in developing countries. Moreover, the available (2-, 4-, and 9-valent) vaccines based on virus-like particles, despite their proven effectiveness and safety, present some limitations in terms of system development cost, transport cold chain, and oncogenic HPV variants. In addition, vaccination programs face some challenges, leading to a considerable burden of HPV infection and related diseases. Therefore, even though the new (9-valent) vaccine seems promising, next-generation vaccines as well as awareness programs associated with HPV vaccination and budget reinforcements for immunization are needed. Frontiers Media S.A. 2021-01-20 /pmc/articles/PMC7855977/ /pubmed/33553082 http://dx.doi.org/10.3389/fpubh.2020.552028 Text en Copyright © 2021 Kombe Kombe, Li, Zahid, Mengist, Bounda, Zhou and Jin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Kombe Kombe, Arnaud John Li, Bofeng Zahid, Ayesha Mengist, Hylemariam Mihiretie Bounda, Guy-Armel Zhou, Ying Jin, Tengchuan Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title | Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title_full | Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title_fullStr | Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title_full_unstemmed | Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title_short | Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation |
title_sort | epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855977/ https://www.ncbi.nlm.nih.gov/pubmed/33553082 http://dx.doi.org/10.3389/fpubh.2020.552028 |
work_keys_str_mv | AT kombekombearnaudjohn epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT libofeng epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT zahidayesha epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT mengisthylemariammihiretie epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT boundaguyarmel epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT zhouying epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation AT jintengchuan epidemiologyandburdenofhumanpapillomavirusandrelateddiseasesmolecularpathogenesisandvaccineevaluation |